Switch to:

Horizon Therapeutics EV-to-Revenue

: 11.54 (As of Today)
View and export this data going back to 2011. Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Horizon Therapeutics's enterprise value is $17,507 Mil. Horizon Therapeutics's Revenue for the trailing twelve months (TTM) ended in Jun. 2020 was $1,518 Mil. Therefore, Horizon Therapeutics's EV-to-Revenue for today is 11.54.

NAS:HZNP' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.5   Med: 4.6   Max: 30.2
Current: 11.54

0.5
30.2

During the past 12 years, the highest EV-to-Revenue of Horizon Therapeutics was 30.20. The lowest was 0.50. And the median was 4.60.

NAS:HZNP's EV-to-Revenue is ranked lower than
84% of the 968 Companies
in the Drug Manufacturers industry.

( Industry Median: 3.07 vs. NAS:HZNP: 11.54 )

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2020-10-25), Horizon Therapeutics's stock price is $77.44. Horizon Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2020 was $7.32. Therefore, Horizon Therapeutics's PS Ratio for today is 10.57.


Horizon Therapeutics EV-to-Revenue Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Horizon Therapeutics Annual Data
Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
EV-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.94 3.99 3.36 3.50 5.44

Horizon Therapeutics Quarterly Data
Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20
EV-to-Revenue Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.87 4.29 5.44 4.53 7.60

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Horizon Therapeutics EV-to-Revenue Distribution

* The bar in red indicates where Horizon Therapeutics's EV-to-Revenue falls into.



Horizon Therapeutics EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Horizon Therapeutics's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=17507.266/1517.699
=11.54

Horizon Therapeutics's current Enterprise Value is $17,507 Mil.
Horizon Therapeutics's Revenue for the trailing twelve months (TTM) ended in Jun. 2020 was 335.466 (Sep. 2019 ) + 363.545 (Dec. 2019 ) + 355.909 (Mar. 2020 ) + 462.779 (Jun. 2020 ) = $1,518 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Horizon Therapeutics  (NAS:HZNP) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Horizon Therapeutics's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=77.44/7.323
=10.57

Horizon Therapeutics's share price for today is $77.44.
Horizon Therapeutics's Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2020 was 1.728 (Sep. 2019 ) + 1.322 (Dec. 2019 ) + 1.872 (Mar. 2020 ) + 2.401 (Jun. 2020 ) = $7.32.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Horizon Therapeutics EV-to-Revenue Related Terms


Horizon Therapeutics EV-to-Revenue Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)